🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07832968
Starting soon Not applicable

Mulligan Technique Versus Proprioceptive Training in Cervicogenic Headache

NCT07832968 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-09-24
Last updated
2026-09-22

Condition(s) studied

Cervicogenic Headache

Investigational drug(s) / intervention(s)

Mulligan TechniqueProprioceptive TrainingConventional physical therapy program

Mulligan Technique: Mulligan Mobilization Technique will include Headache SNAG, Reverse Headache SNAG, and C1-C2 SNAG rotation. All techniques will be performed with the participant sitting in an erect posture. Headache SNAG and Reverse Headache SNAG will be applied at C2 for 10-30 seconds, with a maximum of 10 repetitions. C1-C2 SNAG rotation will be performed toward the restricted side for 10 repetitions with end-range overpressure and 30 seconds of rest between repetitions. The intervention will be administered in addition to the conventional physical therapy program for 12 sessions, 3 sessions per week for 4 weeks.

Proprioceptive Training: Proprioceptive training will include head relocation practice, cervical joint position retraining, and oculomotor exercises. Joint position sense will be trained using a head-mounted laser pointer with head movements and relocation to the neutral position, progressing from eyes open to eyes closed. Cervical joint position retraining will include tracing patterns with the laser. Oculomotor training will include eye-follow, saccades, gaze stability, and eye-head coordination exercises, with progression by increasing movement speed and range and modifying visual targets. The intervention will be administered in addition to the conventional physical therapy program for 12 sessions, 3 sessions per week for 4 weeks.

Conventional physical therapy program: The conventional physical therapy program will include hot pack application for 10 minutes, therapeutic ultrasound for 5 minutes on each side at an intensity of 1-1.5 W/cm² over the trapezius, upper cervical, and occipitovertebral regions, and low-load endurance exercises for the craniocervical and cervicoscapular muscles. The exercise program will include craniocervical flexion training using pressure biofeedback and scapular muscle endurance exercises. The conventional program will be administered to participants in both study arms.

Study summary

This study will be conducted to compare the effectiveness of mulligan versus proprioceptive training on pain severity, headache disability, flexion rotation test, pain threshold, cervical joint position error in patients with cervicogenic headache.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * CGH pain intensity between 3 and 8 on 10-point pain scale. * CGH due to cervical spine dysfunction. * Reduced cervical motion. * Neck pain followed by headache. * Unilateral pain starting in the neck and radiating to the frontotemporal region. * Reproduction of the headache on palpation of the upper cervical spine (C0 to C3). Exclusion Criteria: * Participants with other types of headache (migraine). * Headache due to other causes (sinus, tumor, neural, or temporomandibular joint issues), and any type of physical therapy treatment in the past three months. * Any contraindications to manual and manipulative therapy (fracture, instability, osteoporosis, arthropathy, or neural symptoms). * Using analgesics or corticosteroids. * Metastasis. * Cardiac conditions (stroke, hypertension, or syncope). * Neurological conditions (radiculopathy, myelopathy, or disc problems). * Spinal cord problem. * Previous brain and spinal cord surgery.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Outpatient clinic of faculty of physical therapy Suez Canal university Ismailia Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07832968 on ClinicalTrials.gov ↗ ← All trials in Egypt